Pure Global AI
NCT06385106Not yet recruiting

Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease

Effects of Repetitive Transcranial Magnetic Stimulation on Sleep and Cognitive Function in Patients With Alzheimer's Disease: a Randomized, Double-blind, Controlled Study
First Affiliated Hospital of Zhejiang UniversityClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Alzheimer Disease
Drug/Device/Intervention
Real repetitive transcranial magnetic stimulation
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
First Affiliated Hospital of Zhejiang University
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2024
End date
Jan 01, 2025
Enrollment
30 participants
Primary outcome

Cognitive funtion,Sleep parameters

Summary

Previous studies have shown that repetitive transcranial magnetic stimulation (rTMS) can
 improve cognitive function in Alzheimer's disease (AD), but studies on the improvement of
 sleep disorders in AD are limited. The aim of this study was to evaluate the effects of rTMS
 on sleep and cognition in patients with mild-to-moderate Alzheimer's disease (AD).

ICD-10 classifications
Alzheimer diseaseAlzheimer disease, unspecifiedOther Alzheimer diseaseDementia in Alzheimer diseaseDementia in Alzheimer disease, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06385106
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06385106 through Pure Global AI's free database. This phase not specified trial is sponsored by First Affiliated Hospital of Zhejiang University and is currently Not yet recruiting. The study focuses on Alzheimer Disease. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.